Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Chronic Subdural Hematoma
NCT02024373Phase 2Completed
- Sponsor
- Oriental Neurosurgery Evidence-Based-Study Team
- Start
- Dec 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic subdural hematoma (CSDH) comparing Atorvastatin with Placebo (2 arms). Primary endpoint: Hematoma Reduced Amount at 8 weeks. Started Dec 2013; status: completed.
02
Drugs
atorvastatin
03
Conditions
chronic subdural hematoma (CSDH)
Beyond the preview
Go deeper on NCT02024373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02024373.